These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8743918)

  • 1. Clinical significance of serum hyaluronan in patients with chronic viral liver disease.
    Murawaki Y; Ikuta Y; Koda M; Nishimura Y; Kawasaki H
    J Gastroenterol Hepatol; 1996 May; 11(5):459-65. PubMed ID: 8743918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology.
    Murawaki Y; Ikuta Y; Koda M; Kawasaki H
    Hepatology; 1994 Oct; 20(4 Pt 1):780-7. PubMed ID: 7927217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-prandial serum hyaluronan concentration in patients with chronic liver disease.
    Idobe Y; Murawaki Y; Ikuta Y; Koda M; Kawasaki H
    Intern Med; 1998 Jul; 37(7):568-75. PubMed ID: 9711881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum hyaluronan--a non-invasive test for diagnosing liver cirrhosis.
    Plevris JN; Haydon GH; Simpson KJ; Dawkes R; Ludlum CA; Harrison DJ; Hayes PC
    Eur J Gastroenterol Hepatol; 2000 Oct; 12(10):1121-7. PubMed ID: 11057458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serum 7S fragment of type IV collagen and serum central triple-helix of type IV collagen for assessment of liver fibrosis in patients with chronic viral liver disease.
    Murawaki Y; Ikuta Y; Koda M; Yamada S; Kawasaki H
    J Hepatol; 1996 Feb; 24(2):148-54. PubMed ID: 8907567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive determination of liver collagen content in chronic hepatitis. Multivariate regression modeling with blood chemical parameters as variables.
    Takamatsu S; Nakabayashi H; Okamoto Y; Nakano H
    J Gastroenterol; 1997 Jun; 32(3):355-60. PubMed ID: 9213250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of serum 7S collagen and type VI collagen levels for the diagnosis of hepatic fibrosis.
    Ji X; Li S; Kong X; Xu G; Chen J; Dai X
    Chin Med J (Engl); 1997 Mar; 110(3):198-201. PubMed ID: 9594340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy.
    Guéchot J; Loria A; Serfaty L; Giral P; Giboudeau J; Poupon R
    J Hepatol; 1995 Jan; 22(1):22-6. PubMed ID: 7751583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis.
    Guéchot J; Laudat A; Loria A; Serfaty L; Poupon R; Giboudeau J
    Clin Chem; 1996 Apr; 42(4):558-63. PubMed ID: 8605673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum hyaluronan as a marker of liver fibrosis in asymptomatic chronic viral hepatitis B.
    Pontinha N; Pessegueiro H; Barros H
    Scand J Clin Lab Invest; 1999 Aug; 59(5):343-7. PubMed ID: 10533846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease.
    Santos VN; Leite-Mór MM; Kondo M; Martins JR; Nader H; Lanzoni VP; Parise ER
    Braz J Med Biol Res; 2005 May; 38(5):747-53. PubMed ID: 15917956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance.
    Zheng M; Cai W; Weng H; Liu R
    Chin Med J (Engl); 2003 Mar; 116(3):346-9. PubMed ID: 12781034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
    Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis.
    Guéchot J; Serfaty L; Bonnand AM; Chazouillères O; Poupon RE; Poupon R
    J Hepatol; 2000 Mar; 32(3):447-52. PubMed ID: 10735615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients.
    Attallah AM; Omran D; Omran MM; Albannan MS; Zayed RA; Saif S; Farid A; Hassany M; Yosry A
    Br J Biomed Sci; 2018 Jan; 75(1):19-23. PubMed ID: 28945150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan.
    Bentsen KD; Horn T; Risteli J; Risteli L; Engström-Laurent A; Hørslev-Petersen K; Lorenzen I
    Liver; 1987 Dec; 7(6):339-46. PubMed ID: 3437796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Procollagen III and laminin in chronic viral hepatopathies].
    Montalto G; Soresi M; Aragona F; Tripi S; Carroccio A; Anastasi G; Magliarisi C; Barresi E; Notarbartolo A
    Presse Med; 1996 Jan; 25(2):59-62. PubMed ID: 8745719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M; Onuk MD; Akçay F; Savas MC
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of serum matrix metalloproteinase-2 concentration in patients with chronic viral liver disease.
    Murawaki Y; Yamada S; Ikuta Y; Kawasaki H
    J Hepatol; 1999 Jun; 30(6):1090-8. PubMed ID: 10406188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.